195 related articles for article (PubMed ID: 26284768)
1. 18F-Florbetapir and 18F-FDG PET/CT in Systemic Immunoglobulin Light Chain Amyloidosis Involving the Peripheral Nerves.
Broski SM; Spinner RJ; Howe BM; Dispenzieri A; Johnson GB
Clin Nucl Med; 2016 Feb; 41(2):e115-7. PubMed ID: 26284768
[TBL] [Abstract][Full Text] [Related]
2. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body
Ehman EC; El-Sady MS; Kijewski MF; Khor YM; Jacob S; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Falk RH; Hyun H; Dorbala S
J Nucl Med; 2019 Sep; 60(9):1234-1239. PubMed ID: 30954943
[TBL] [Abstract][Full Text] [Related]
3. Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis.
Datar Y; Clerc OF; Cuddy SAM; Kim S; Taylor A; Neri JC; Benz DC; Bianchi G; Yee AJ; Sanchorawala V; Ruberg FL; Landau H; Liao R; Kijewski MF; Jerosch-Herold M; Kwong RY; Di Carli MF; Falk RH; Dorbala S
Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):687-697. PubMed ID: 38193678
[TBL] [Abstract][Full Text] [Related]
4. Novel imaging techniques using
Shouman K; Broski SM; Muchtar E; Pendleton CA; Johnson GB; Tracy J; Engelstad JK; Spinner RJ; Dyck PJB
Muscle Nerve; 2021 Jan; 63(1):104-108. PubMed ID: 33094511
[TBL] [Abstract][Full Text] [Related]
5. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
Cuddy SAM; Bravo PE; Falk RH; El-Sady S; Kijewski MF; Park MA; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Cheng SC; Jerosch-Herold M; Kwong RY; Liao R; Dorbala S
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1325-1336. PubMed ID: 32417333
[TBL] [Abstract][Full Text] [Related]
6. 18 F-Florbetapir PET/CT and 68 Ga-FAPI PET/CT in a Case of Light Chain Amyloidosis With Predominant Multiple Tumor-Like Deposits.
Zhang Y; Wang X; Ren C; Shen K; Huo L
Clin Nucl Med; 2024 May; 49(5):486-488. PubMed ID: 38465960
[TBL] [Abstract][Full Text] [Related]
7. Extracardiac
Wagner T; Page J; Burniston M; Skillen A; Ross JC; Manwani R; McCool D; Hawkins PN; Wechalekar AD
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1129-1138. PubMed ID: 29651545
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review.
Mekinian A; Jaccard A; Soussan M; Launay D; Berthier S; Federici L; Lefèvre G; Valeyre D; Dhote R; Fain O;
Amyloid; 2012 Jun; 19(2):94-8. PubMed ID: 22587492
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma.
Son YM; Choi JY; Bak CH; Cheon M; Kim YE; Lee KH; Kim BT
Korean J Radiol; 2011; 12(5):634-7. PubMed ID: 21927567
[TBL] [Abstract][Full Text] [Related]
10. A pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement.
Manwani R; Page J; Lane T; Burniston M; Skillen A; Lachmann HJ; Gillmore JD; Fontana M; Whelan C; Hawkins PN; Wagner T; Wechalekar AD
Amyloid; 2018 Dec; 25(4):247-252. PubMed ID: 30661419
[No Abstract] [Full Text] [Related]
11. Utility of the
Mestre-Torres J; Lorenzo-Bosquet C; Cuberas-Borrós G; Gironella M; Solans-Laque R; Fernández-Codina A; Bujan-Rivas S; Castell-Conesa J; Martínez-Valle F
Amyloid; 2018 Jun; 25(2):109-114. PubMed ID: 29706127
[TBL] [Abstract][Full Text] [Related]
12. Quantitative [
Khor YM; Cuddy S; Harms HJ; Kijewski MF; Park MA; Robertson M; Hyun H; Di Carli MF; Bianchi G; Landau H; Yee A; Sanchorawala V; Ruberg FL; Liao R; Berk J; Falk RH; Dorbala S
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1998-2009. PubMed ID: 31807884
[TBL] [Abstract][Full Text] [Related]
13. Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis.
Glaudemans AW; Slart RH; Noordzij W; Dierckx RA; Hazenberg BP
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1095-101. PubMed ID: 23474745
[TBL] [Abstract][Full Text] [Related]
14. Visualization of amyloid arthropathy in light-chain systemic amyloidosis on F-18 FDG PET/CT scan.
Mekinian A; Ghrenassia E; Pop G; Roberts S; Prendki V; Stirnemann J; Weinmann P; Fain O
Clin Nucl Med; 2011 Jan; 36(1):52-3. PubMed ID: 21157212
[TBL] [Abstract][Full Text] [Related]
15. Is 18F-flutemetamol PET/CT able to reveal cardiac amyloidosis?
Lhommel R; Sempoux C; Ivanoiu A; Michaux L; Gerber B
Clin Nucl Med; 2014 Aug; 39(8):747-9. PubMed ID: 24978329
[TBL] [Abstract][Full Text] [Related]
16. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S
Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET scanning in pulmonary amyloidosis.
Baqir M; Lowe V; Yi ES; Ryu JH
J Nucl Med; 2014 Apr; 55(4):565-8. PubMed ID: 24556593
[TBL] [Abstract][Full Text] [Related]
18. 18F-Florbetaben: A New Tool for Amyloidosis Staging?
D'Estanque E; Chambert B; Moranne O; Kotzki PO; Boudousq V
Clin Nucl Med; 2017 Jan; 42(1):50-53. PubMed ID: 27801739
[TBL] [Abstract][Full Text] [Related]
19. 18F-Florbetapir PET in Primary Cerebral Amyloidoma.
Soffers F; Ceyssens S; Buffet W; de Surgeloose D; Crols R
Clin Nucl Med; 2020 Oct; 45(10):838-839. PubMed ID: 32796236
[TBL] [Abstract][Full Text] [Related]
20. Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.
Dorbala S; Vangala D; Semer J; Strader C; Bruyere JR; Di Carli MF; Moore SC; Falk RH
Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1652-62. PubMed ID: 24841414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
